Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats

Gui-Feng LuFei GengLi-Ping DengDa-Cen LinYan-Zhen HuangSu-Mei LaiYi-Chen LinLong-Xin GuiJames S.K. ShamMo-Jun LinKey Laboratory of Fujian Province Universities on Ion Channel and Signal Transduction in Cardiovascular Diseases,Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Fujian Medical University,Fuzhou,Fujian Province,People's Republic of China (G.-F.L.,L.-P.D.,Y.-Z.H.,S.-M.L.,Y.-C.L.,L.-X.G.,M.-J.L.).Department of Physiology and Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology,Shantou University Medical College,Shantou,Guangdong province,People's Republic of China (F.G.).Department of Epidemiology and Health Statistics,School of Public Health,Fujian Medical University,Fuzhou,Fujian Province,People's Republic of China (D.-C.L.).Division of Pulmonary and Critical Care Medicine,Johns Hopkins University School of Medicine,Baltimore,Maryland,USA (J.S.K.S.)

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.122.19183

IF: 9.8968

2022-08-24

Hypertension

Abstract:Pulmonary arterial hypertension maintains rapid cell proliferation and vascular remodeling through metabolic reprogramming. Recent studies suggested that circRNAs play important role in pulmonary vascular remodeling and pulmonary arterial smooth muscle cells proliferation. However, the relationship between circRNA, cell proliferation, and metabolic reprogramming in pulmonary arterial hypertension has not been investigated. RNA-seq and qRT-PCR reveal the differential expression profile of circRNA in pulmonary arteries of pulmonary arterial hypertension rat models. Transfection was used to examine the effects of circSMOC1 on pulmonary artery smooth muscle cells, and the roles of circSMOC1 in vivo were investigated by adenoassociated virus. Mass spectrometry, RNA pull-down, RNA immunoprecipitation, and dual-luciferase reporter assay were performed to investigate the signaling pathway of circSMOC1 regulating the metabolic reprogramming. CircSMOC1 was significantly downregulated in pulmonary arteries of pulmonary arterial hypertension rats. CircSMOC1 knockdown promoted proliferation and migration and enhanced aerobic glycolysis of pulmonary artery smooth muscle cells. CircSMOC1 overexpression in vivo alleviates pulmonary vascular remodeling, right ventricular pressure, and right heart hypertrophy. In the nucleus, circSMOC1 directly binds to PTBP1 (polypyrimidine tract-binding protein), competitively inhibits the specific splicing of PKM (pyruvate kinase M) premRNA, resulting in the upregulation of PKM2 (pyruvate kinase M2), the key enzyme of aerobic glycolysis, to enhance glycolysis. In the cytoplasm, circSMOC1 acted as a miR-329-3p sponge, and its reduction in pulmonary arterial hypertension suppressed PDHB (pyruvate dehydrogenase E1 subunit beta) expression, leading to the impairment of mitochondrial oxidative phosphorylation. circSMOC1 is crucially involved in the metabolic reprogramming of pulmonary artery smooth muscle cells through PTBP1 and miR-329-3p to regulate pulmonary vascular remodeling in pulmonary arterial hypertension.

peripheral vascular disease

What problem does this paper attempt to address?

Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats

CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension

Hsa_circ_0008360 Sponges Mir-186-5p to Target CCND2 to Modulate High Glucose-Induced Vascular Endothelial Dysfunction.

Loss of M6a Demethylase ALKBH5 Alleviates Hypoxia-Induced Pulmonary Arterial Hypertension Via Inhibiting Cyp1a1 Mrna Decay

Circ-calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation

CircLMBR1 inhibits phenotypic transformation of hypoxia-induced pulmonary artery smooth muscle via the splicing factor PUF60

Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis

CircPMS1 Promotes Proliferation of Pulmonary Artery Smooth Muscle Cells, Pulmonary Microvascular Endothelial Cells, and Pericytes under Hypoxia.

Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension

CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension

CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.

Circ-Bptf Serves As a Mir-486-5p Sponge to Regulate CEMIP and Promotes Hypoxic Pulmonary Arterial Smooth Muscle Cell Proliferation in COPD

CircATP2B4 promotes hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the miR-223/ATR axis

CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR‐509‐5p/multiple C2 and transmembrane domain containing 2 axis

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

Circ-BPTF Associated Pulmonary Vascular Remodeling in COPD Via Promoting Smooth Muscle Cells Proliferation by MiR-486-5p/CEMIP Axis

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

Hsa_circwdr37_016 Regulates Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells

CircNAP1L4 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation Via the NAP1L4-mediated Super- Enhancerdriven Glycolysis Gene Hexokinase II (HK II) in Pulmonary Hypertension

Overexpressed lncRNA AC068039.4 contributes to proliferation and cell cycle progression of pulmonary artery smooth muscle cells via sponging miR-26a-5p/TRPC6 in hypoxic pulmonary arterial hypertension

MiR-125a Regulates Mitochondrial Homeostasis Through Targeting Mitofusin 1 to Control Hypoxic Pulmonary Vascular Remodeling